Niloofar Rahmani

Array ( [id] => 5113668 [patent_doc_number] => 20070197584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'ARYL-SUBSTITUTED POLYCYCLIC AMINES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF AS A MEDICAMENT' [patent_app_type] => utility [patent_app_number] => 11/675646 [patent_app_country] => US [patent_app_date] => 2007-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14894 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20070197584.pdf [firstpage_image] =>[orig_patent_app_number] => 11675646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 142185 [patent_doc_number] => 07691877 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-06 [patent_title] => 'Pharmaceuticals' [patent_app_type] => utility [patent_app_number] => 11/675667 [patent_app_country] => US [patent_app_date] => 2007-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57879 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/691/07691877.pdf [firstpage_image] =>[orig_patent_app_number] => 11675667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4989435 [patent_doc_number] => 20070155776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'THIENOPYRIDINE AND FUROPYRIDINE KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/675183 [patent_app_country] => US [patent_app_date] => 2007-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 172041 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20070155776.pdf [firstpage_image] =>[orig_patent_app_number] => 11675183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 318765 [patent_doc_number] => 07521475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-21 [patent_title] => 'Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/674245 [patent_app_country] => US [patent_app_date] => 2007-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18281 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/521/07521475.pdf [firstpage_image] =>[orig_patent_app_number] => 11674245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120538 [patent_doc_number] => 20070142253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Cyclopropanated Macrocyclic Ketones and Lactones' [patent_app_type] => utility [patent_app_number] => 11/674523 [patent_app_country] => US [patent_app_date] => 2007-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4561 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142253.pdf [firstpage_image] =>[orig_patent_app_number] => 11674523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 173904 [patent_doc_number] => 07659283 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-09 [patent_title] => 'Pyrrolo [3,2-C] pyridines useful as inhibitors of protein kinases' [patent_app_type] => utility [patent_app_number] => 11/705556 [patent_app_country] => US [patent_app_date] => 2007-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12481 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/659/07659283.pdf [firstpage_image] =>[orig_patent_app_number] => 11705556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368829 [patent_doc_number] => 20090306388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'METHOD FOR SUBSTITUTED IH-IMIDAZO[4,5-C] PYRIDINES' [patent_app_type] => utility [patent_app_number] => 12/278872 [patent_app_country] => US [patent_app_date] => 2007-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9966 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306388.pdf [firstpage_image] =>[orig_patent_app_number] => 12278872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 334338 [patent_doc_number] => 07507750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-24 [patent_title] => 'Stabilized ascorbic acid derivative' [patent_app_type] => utility [patent_app_number] => 11/672677 [patent_app_country] => US [patent_app_date] => 2007-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13012 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/507/07507750.pdf [firstpage_image] =>[orig_patent_app_number] => 11672677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5310875 [patent_doc_number] => 20090018156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Pyrrolo [2,3,B] Pyridine Derivatives Useful As RAF Kinase Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/162811 [patent_app_country] => US [patent_app_date] => 2007-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17042 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018156.pdf [firstpage_image] =>[orig_patent_app_number] => 12162811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5297171 [patent_doc_number] => 20090012097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Polycyclic 1,2,3,4-Tetrahydro-Isoquinoline Derivatives and Compositions Comprising Them As Ppar Modulators' [patent_app_type] => utility [patent_app_number] => 12/160305 [patent_app_country] => US [patent_app_date] => 2007-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12476 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012097.pdf [firstpage_image] =>[orig_patent_app_number] => 12160305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070259 [patent_doc_number] => 20070191361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'AMINOTROPANE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF' [patent_app_type] => utility [patent_app_number] => 11/626973 [patent_app_country] => US [patent_app_date] => 2007-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15244 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191361.pdf [firstpage_image] =>[orig_patent_app_number] => 11626973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6628860 [patent_doc_number] => 20100004239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Pyrrolo [3,2-C] Pyridine-4-One 2-Indolinone Protein Kinase Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/223180 [patent_app_country] => US [patent_app_date] => 2007-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63951 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004239.pdf [firstpage_image] =>[orig_patent_app_number] => 12223180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6644886 [patent_doc_number] => 20100227880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'CHEMICAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/161800 [patent_app_country] => US [patent_app_date] => 2007-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35316 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227880.pdf [firstpage_image] =>[orig_patent_app_number] => 12161800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 142102 [patent_doc_number] => 07687515 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-30 [patent_title] => '6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives' [patent_app_type] => utility [patent_app_number] => 11/653600 [patent_app_country] => US [patent_app_date] => 2007-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18760 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/687/07687515.pdf [firstpage_image] =>[orig_patent_app_number] => 11653600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5005647 [patent_doc_number] => 20070203219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Production of dolasetron' [patent_app_type] => utility [patent_app_number] => 11/650294 [patent_app_country] => US [patent_app_date] => 2007-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16884 [patent_no_of_claims] => 100 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203219.pdf [firstpage_image] =>[orig_patent_app_number] => 11650294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539806 [patent_doc_number] => 20090221611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Fused Triazole Tachykinin Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 12/087187 [patent_app_country] => US [patent_app_date] => 2007-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12686 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221611.pdf [firstpage_image] =>[orig_patent_app_number] => 12087187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5237240 [patent_doc_number] => 20070129397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Ester derivatives' [patent_app_type] => utility [patent_app_number] => 11/648614 [patent_app_country] => US [patent_app_date] => 2007-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33990 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20070129397.pdf [firstpage_image] =>[orig_patent_app_number] => 11648614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564770 [patent_doc_number] => 20090137623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'MUSCARINIC RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/158435 [patent_app_country] => US [patent_app_date] => 2007-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16296 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137623.pdf [firstpage_image] =>[orig_patent_app_number] => 12158435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558799 [patent_doc_number] => 20090270376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'HETEROCYCLIC JANUS KINASE 3 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/065234 [patent_app_country] => US [patent_app_date] => 2006-12-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52931 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270376.pdf [firstpage_image] =>[orig_patent_app_number] => 12065234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7687514 [patent_doc_number] => 20090176777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Imidazo (1,2-a)Pyridin-3-YL-Acetic Acid Hydrazides, Proesses for Their Preparation and Pharmaceutical Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/087423 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5141 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176777.pdf [firstpage_image] =>[orig_patent_app_number] => 12087423 [rel_patent_id] =>[rel_patent_doc_number] =>)